CTRI Number |
CTRI/2021/04/032490 [Registered on: 01/04/2021] Trial Registered Prospectively |
Last Modified On: |
02/04/2021 |
Post Graduate Thesis |
No |
Type of Trial |
Observational |
Type of Study
|
Cross Sectional Study |
Study Design |
Other |
Public Title of Study
|
The prevalence of anxiety and depression, measured objectively, in patients diagnosed to have asthma and COPD attending a teaching hospital |
Scientific Title of Study
|
The prevalence of anxiety and depression in diagnosed obstructive airway diseased patients attending a tertiary care centre a cross sectional study |
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Bhadra Sajeev Nair |
Designation |
M.B.B.S Student |
Affiliation |
Malankara orthodox syrian church medical college hospital |
Address |
Chandramangalam, Thonnanmakkil(H), Ettumanoor P.O Kottayam, kerala, India 686631 Department of Pulmonary medicine, room no-12 faculty block, Malankara orthodox syrian church medical college hospital,Kolenchery, Ernakulam, India 682311 Kottayam KERALA 686631 India |
Phone |
9061700569 |
Fax |
|
Email |
bhadranair718@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Jijo Oommen Roy |
Designation |
Consultant pulmonologist |
Affiliation |
Malankara orthodox syrian church medical college hospital |
Address |
Department of Pulmonary medicine, room no-12 faculty block, Malankara orthodox syrian church medical college hospital,Kolenchery, Ernakulam, India 682311 Department of Pulmonary medicine, room no-12 faculty block, Malankara orthodox syrian church medical college hospital,Kolenchery, Ernakulam, India 682311 Ernakulam KERALA 682311 India |
Phone |
8606385885 |
Fax |
|
Email |
drjijoroy@gmail.com |
|
Details of Contact Person Public Query
|
Name |
Bhadra Sajeev Nair |
Designation |
M.B.B.S Student |
Affiliation |
Malankara orthodox syrian church medical college hospital |
Address |
Chandramangalam, Thonnanmakkil(H), Ettumanoor P.O Kottayam, Kerala, India 686631 Department of Pulmonary medicine, room no-12 faculty block, Malankara orthodox syrian church medical college hospital,Kolenchery, Ernakulam, India 682311 Kottayam KERALA 686631 India |
Phone |
9061700569 |
Fax |
|
Email |
bhadranair718@gmail.com |
|
Source of Monetary or Material Support
|
Indian council of medical research (ICMR), Short term studentship(STS) scholarship 2020 |
|
Primary Sponsor
|
Name |
Indian council of medical research ICMR |
Address |
V. Ramalingaswami Bhawan, P.O. Box No. 4911
Ansari Nagar, New Delhi - 110029, India |
Type of Sponsor |
Government funding agency |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Bhadra Sajeev Nair |
Malankara Orthodox Syrian Church Medical College Hospital |
Department of Pulmonary medicine, Room no 12- Faculty department
Kolenchery, Ernakulam, India 682311 Ernakulam KERALA |
9061700569
bhadranair718@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Institutional ethics commiittee Malankara orthodox syrian church medical college hospital |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition: J449||Chronic obstructive pulmonary disease, unspecified, (2) ICD-10 Condition: J459||Other and unspecified asthma, |
|
Intervention / Comparator Agent
|
|
Inclusion Criteria
|
Age From |
18.00 Year(s) |
Age To |
90.00 Year(s) |
Gender |
Both |
Details |
Diagnosed asthma and COPD male and female patients above 18 years of age was included |
|
ExclusionCriteria |
Details |
Uncooperative patients and patients below 18 years of age were excluded |
|
Method of Generating Random Sequence
|
Not Applicable |
Method of Concealment
|
Not Applicable |
Blinding/Masking
|
Not Applicable |
Primary Outcome
|
Outcome |
TimePoints |
The prevalence of anxiety and depression in diagnosed asthma and chronic obstructive lung disease(COPD) patients attending a respiratory medicine out patient department (OPD) of a developing country |
2 months |
|
Secondary Outcome
|
Outcome |
TimePoints |
Association between severity of anxiety and depression with levels of asthma and chronic obstructive lung disease(COPD) in diagnosed patients |
3 Months |
|
Target Sample Size
|
Total Sample Size="77" Sample Size from India="77"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
N/A |
Date of First Enrollment (India)
|
02/04/2021 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="0" Months="5" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
Recruitment Status of Trial (India) |
Open to Recruitment |
Publication Details
|
NIL |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - YES
- What data in particular will be shared?
Response - All of the individual participant data collected during the trial, after de-identiļ¬cation.
- What additional supporting information will be shared?
Response - Study Protocol Response - Statistical Analysis Plan Response - Informed Consent Form Response - Clinical Study Report
- Who will be able to view these files?
Response - Anyone
- For what types of analyses will this data be available?
Response - Any purpose.
- By what mechanism will data be made available?
Response - Proposals should be directed to [bhadranair718@gmail.com].
- For how long will this data be available start date provided 01-01-2022 and end date provided 01-01-2027?
Response - Immediately following publication. No end date.
- Any URL or additional information regarding plan/policy for sharing IPD?
Additional Information - NIL
|
Brief Summary
|
It is found that there is an increased incidence of Anxiety and Depression in patients with Obstructive Airway Diseases, as compared to general population. But prevalence of the issue as well as number of studies relating to it is very less in developing countries such as India. My study pose to estimate the prevalence of Anxiety and Depression in diagnosed Asthma and COPD patients objectively using Generalised Anxiety Disorder (GAD-7) and Patient Health Questionnaire (PHQ-9) scales respectively, and the data will be analysed statistically. The level of asthma and COPD will be assessed by the consultant pulmonologist using Global Initiative for Asthma (GINA) and Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines respectively. The Anxiety and Depression score obtained from GAD-7 and PHQ-9 scales respectively will be assessed along with the levels of Asthma and COPD obtained from GINA and GOLD guidelines and relation between the two will be statistically analysed. |